no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth
|
Tanno, Toshihiko |
|
|
1 |
15 |
p. 1107-1119 |
article |
2 |
A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies
|
Liu, Shu-Hui |
|
|
1 |
15 |
p. 1088-1100 |
article |
3 |
A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2
|
Khalil, Shadi |
|
|
1 |
15 |
p. 1181-1194 |
article |
4 |
Clonality of HTLV-1–infected T cells as a risk indicator for development and progression of adult T-cell leukemia
|
Firouzi, Sanaz |
|
|
1 |
15 |
p. 1195-1205 |
article |
5 |
Copy number alterations detected as clonal hematopoiesis of indeterminate potential
|
Takahashi, Koichi |
|
|
1 |
15 |
p. 1031-1036 |
article |
6 |
Editorial Board
|
|
|
|
1 |
15 |
p. i |
article |
7 |
Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study
|
Kanias, Tamir |
|
|
1 |
15 |
p. 1132-1141 |
article |
8 |
Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: mode of its action
|
Keshava, Shiva |
|
|
1 |
15 |
p. 1206-1214 |
article |
9 |
Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels
|
Ma, Qianyi |
|
|
1 |
15 |
p. 1037-1046 |
article |
10 |
12-HETrE inhibits platelet reactivity and thrombosis in part through the prostacyclin receptor
|
Tourdot, Benjamin E. |
|
|
1 |
15 |
p. 1124-1131 |
article |
11 |
High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression
|
Wittwer, Nicole L. |
|
|
1 |
15 |
p. 1067-1079 |
article |
12 |
Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms
|
Ueda, Koki |
|
|
1 |
15 |
p. 1001-1015 |
article |
13 |
Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT
|
Ho, Christine M. |
|
|
1 |
15 |
p. 1056-1066 |
article |
14 |
Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions
|
Sachais, Bruce S. |
|
|
1 |
15 |
p. 1142-1147 |
article |
15 |
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study
|
DeAngelo, Daniel J. |
|
|
1 |
15 |
p. 1167-1180 |
article |
16 |
Lymphadenopathy driven by TCR-Vγ8Vδ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome
|
Vavassori, Stefano |
|
|
1 |
15 |
p. 1101-1106 |
article |
17 |
Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer
|
Mohammed, Yassene |
|
|
1 |
15 |
p. 1080-1087 |
article |
18 |
Novel SF3B1 in-frame deletions result in aberrant RNA splicing in CLL patients
|
Agrawal, Anant A. |
|
|
1 |
15 |
p. 995-1000 |
article |
19 |
Ovarian vein thrombus: to treat or not to treat?
|
Plastini, Trisha |
|
|
1 |
15 |
p. 1120-1123 |
article |
20 |
Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens
|
Westwood, John-Paul |
|
|
1 |
15 |
p. 1159-1166 |
article |
21 |
Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia
|
Sanz, Jaime |
|
|
1 |
15 |
p. 1047-1055 |
article |
22 |
Substrate-bound CCL21 and ICAM1 combined with soluble IL-6 collectively augment the expansion of antigen-specific murine CD4+ T cells
|
Adutler-Lieber, Shimrit |
|
|
1 |
15 |
p. 1016-1030 |
article |
23 |
Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation
|
van Mens, Thijs E. |
|
|
1 |
15 |
p. 1148-1158 |
article |